These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 8818347)

  • 21. Effect of endotoxin and platelet-activating factor on rat vascular permeability: role of vasoactive mediators.
    Balsa D; Merlos M; Giral M; Ferrando R; Garcia-Rafanell J; Forn J
    J Lipid Mediat Cell Signal; 1997 Sep; 17(1):31-45. PubMed ID: 9302653
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Platelet activating factor (PAF) and tumor necrosis factor-alpha (TNF alpha) interactions in endotoxemic shock: studies with BN 50739, a novel PAF antagonist.
    Rabinovici R; Yue TL; Farhat M; Smith EF; Esser KM; Slivjak M; Feuerstein G
    J Pharmacol Exp Ther; 1990 Oct; 255(1):256-63. PubMed ID: 2213560
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sequential release of tumour necrosis factor, platelet activating factor and eicosanoids during endotoxin shock in anaesthetized pigs: protective effects of indomethacin.
    Mózes T; Zijlstra FJ; Heiligers JP; Tak CJ; Ben-Efraim S; Bonta IL; Saxena PR
    Br J Pharmacol; 1991 Nov; 104(3):691-9. PubMed ID: 1797328
    [TBL] [Abstract][Full Text] [Related]  

  • 24. (Pyridylcyanomethyl)piperazines as orally active PAF antagonists.
    Carceller E; Almansa C; Merlos M; Giral M; Bartrolí J; García-Rafanell J; Forn J
    J Med Chem; 1992 Oct; 35(22):4118-34. PubMed ID: 1433215
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of endothelin-1 on vascular permeability in the conscious rat: interactions with platelet-activating factor.
    Filep JG; Sirois MG; Rousseau A; Fournier A; Sirois P
    Br J Pharmacol; 1991 Dec; 104(4):797-804. PubMed ID: 1667286
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of platelet-activating factor on cerebral microcirculation in rats: part 1. Systemic application.
    Uhl E; Pickelmann S; Baethmann A; Schürer L
    Stroke; 1999 Apr; 30(4):873-9; discussion 886. PubMed ID: 10187894
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiac functional and structural alterations induced by endotoxin in rats: importance of platelet-activating factor.
    Iwase M; Yokota M; Kitaichi K; Wang L; Takagi K; Nagasaka T; Izawa H; Hasegawa T
    Crit Care Med; 2001 Mar; 29(3):609-17. PubMed ID: 11373429
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of potassium channel and cytochrome P450 inhibition on transient hypotension and survival during lipopolysaccharide-induced endotoxic shock in the rat.
    Clayton NP; LeDuc BW; Kelly LJ
    Pharmacology; 2005 Mar; 73(3):113-20. PubMed ID: 15499226
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Unexpected action of platelet activating factor antagonism after fluid resuscitation from traumatic shock.
    Schurr MJ; Fabian TC; Croce MA; Geraci SA; Proctor KG
    Surgery; 1997 May; 121(5):493-500. PubMed ID: 9142146
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of Y-24180, a long-acting antagonist to platelet-activating factor (PAF), on PAF-induced reactions: a relationship between the partial structure of the compound and its duration of the action.
    Kagoshima M; Tomomatsu N; Iwahisa Y; Yamaguchi S; Kawakami Y; Terasawa M
    Pharmacology; 1997 May; 54(5):261-70. PubMed ID: 9380772
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ethanol suppresses endotoxin but not platelet activating factor-induced hypotension and nitric oxide.
    Greenberg SS; Xie J; Powers DR; Giles TD
    Alcohol Clin Exp Res; 1996 Oct; 20(7):1260-8. PubMed ID: 8904980
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Beneficial actions of BN 50739, a new PAF receptor antagonist, in murine traumatic shock.
    Karasawa A; Rochester JA; Lefer AM
    Methods Find Exp Clin Pharmacol; 1990 May; 12(4):231-7. PubMed ID: 2165204
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacological actions of WEB 2086, a new specific antagonist of platelet activating factor.
    Casals-Stenzel J; Muacevic G; Weber KH
    J Pharmacol Exp Ther; 1987 Jun; 241(3):974-81. PubMed ID: 3598913
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative study of endotoxin-induced hypotension in kininogen-deficient rats with that in normal rats.
    Ueno A; Ishida H; Oh-ishi S
    Br J Pharmacol; 1995 Mar; 114(6):1250-6. PubMed ID: 7620716
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PF-5901 inhibits gastrointestinal platelet-activating factor synthesis in vivo.
    Hogaboam CM; Donigi-Gale D; Shoupe TS; Wallace JL
    Eur J Pharmacol; 1992 Jun; 216(2):315-8. PubMed ID: 1397016
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Platelet activating factor is one of the mediators involved in endotoxic shock in pigs.
    Mózes T; Heiligers JP; Tak CJ; Zijlstra FJ; Ben-Efraim S; Saxena PR; Bonta IL
    J Lipid Mediat; 1991 Nov; 4(3):309-25. PubMed ID: 1764577
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of the endothelin receptor antagonist, SB 209670, on circulatory failure and organ injury in endotoxic shock in the anaesthetized rat.
    Ruetten H; Thiemermann C; Vane JR
    Br J Pharmacol; 1996 May; 118(1):198-204. PubMed ID: 8733596
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The novel role of platelet-activating factor in protecting mice against lipopolysaccharide-induced endotoxic shock.
    Jeong YI; Jung ID; Lee CM; Chang JH; Chun SH; Noh KT; Jeong SK; Shin YK; Lee WS; Kang MS; Lee SY; Lee JD; Park YM
    PLoS One; 2009 Aug; 4(8):e6503. PubMed ID: 19652714
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biochemical and pharmacological activities of SR 27417, a highly potent, long-acting platelet-activating factor receptor antagonist.
    Herbert JM; Bernat A; Valette G; Gigo V; Lale A; LaPlace MC; Lespy L; Savi P; Maffrand JP; Le Fur G
    J Pharmacol Exp Ther; 1991 Oct; 259(1):44-51. PubMed ID: 1656029
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of a platelet-activating factor antagonist, CV-3988, on different shock models in the rat.
    Toth PD; Mikulaschek AW
    Circ Shock; 1986; 20(3):193-203. PubMed ID: 3802423
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.